By: IPP Bureau
Last updated : February 15, 2026 8:51 am
Pharma powerhouse Torrent Pharmaceuticals has delivered a solid performance for the quarter ended December 31, 2025, posting a net profit of Rs., 577 crore, up from Rs. 485 crore in the same quarter last year.
Revenue from operations for the quarter stood at Rs. 2,599 crore, compared with Rs. 2,377 crore in the year-ago period. Profit before tax came in at Rs. 757 crore, up from Rs. 651 crore a year earlier.
For the nine months ended December 31, 2025, the company reported net profit of Rs. 1,725 crore, a sharp rise from Rs. 1,414 crore in the corresponding period last year. Revenue from operations during the nine-month period climbed to Rs. 7,977 crore, up from Rs. 7,249 crore.
Total expenses for the quarter were Rs. 1,824 crore, compared with Rs. 1,729 crore in the same period last year. Employee benefits expense rose to Rs. 479 crore from Rs. 407 crore, while other expenses increased to Rs. 584 crore from Rs. 539 crore.
Finance costs declined to Rs. 34 crore during the quarter, down from Rs. 48 crore a year earlier. Depreciation and amortisation expense remained steady at Rs. 191 crore.
Earnings per share (face value Rs. 5 each) for the quarter stood at Rs. 17.04, compared with Rs. 14.33 in the corresponding quarter last year. For the nine-month period, earnings per share rose to Rs. 50.96 from Rs. 41.79.
Total comprehensive income for the quarter was Rs. 572 crore, compared with Rs. 478 crore a year ago.
For the full year ended March 31, 2025, the company had reported net profit of Rs. 1,888 crore on revenue from operations of Rs. 9,682 crore.